Efficacy Comparison of Mannitol and Hypertonic Saline  for Traumatic Brain Injury (TBI) Treatment

Arifianto, Muhammad Reza; Ma'ruf, Achmad Zuhro; Ibrahim, Arsyik

doi:10.15562/bmj.v5i3.281

Cited by 3 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 34 ] One of the main conservative therapies to reduce ICP for TBI patients is hyperosmolar therapy. [ 35 ] Currently, only 2 agents are used for this purpose: Mannitol and hypertonic saline (HTS). Both the fluids have no superiority among them, even though latest studies showed that HTS had more benefits than mannitol in reducing ICP.…”

Section: The Usage Of Hypertonic Sodium Lactate In Traumatic Brain Inmentioning

confidence: 99%

Role of hypertonic sodium lactate in traumatic brain injury management

Arifianto¹,

Ma'ruf²,

Ibrahim

et al. 2018

Asian J Neurosurg

Self Cite

View full text Add to dashboard Cite

Traumatic brain injury (TBI) following increased intracranial pressure (ICP) is a neuroemergency case which should be managed promptly to prevent secondary brain injury. This will lead to a condition called cerebral energy dysfunction which is an important determinant factor toward worse outcome. Lactate, which was historically known as an end waste product, now is considered as an alternative cerebral energetic fuel. Hypertonic sodium lactate (HSL) is a promising hyperosmolar fluid which serves not only to decrease ICP but also to readily supply exogenous lactate to fulfill increased cerebral energy demand. Pioneer studies have shown the harmlessness and usefulness of HSL in treating pathological condition including TBI.

show abstract

Section: The Usage Of Hypertonic Sodium Lactate In Traumatic Brain Inmentioning

confidence: 99%

Role of hypertonic sodium lactate in traumatic brain injury management

Arifianto¹,

Ma'ruf²,

Ibrahim

et al. 2018

Asian J Neurosurg

Self Cite

View full text Add to dashboard Cite

show abstract

“…Injured cells tend to have dysfunctional transport mechanism within plasma membrane. This leads to sodium and calcium accumulation in cytoplasm that eventually leads to cellular edema [2] .…”

Section: Introductionmentioning

confidence: 99%

“…Hyperosmolar fluid administration, such as mannitol or hypertonic saline, has been proven to be 955 effective in reducing ICP. While some studies favored hypertonic saline over mannitol, however it is still difficult to prove the superiority between the two fluids because of the heterogeneity of the studies; so, which is more effective remains a matter of debate [2] .…”

Section: Introductionmentioning

confidence: 99%

Original Article: Hypertonic Saline Versus Mannitol Therapy in Traumatic Brain Injured Patients Guiding by Transcranial Doppler Pulsatile Index in Zagazig University Hospital

Salem¹,

Othman²,

Abdel-Razek

et al. 2018

The Medical Journal of Cairo University

View full text Add to dashboard Cite

Background: Hyperosmolar therapy is the primary medical management strategy for brain edema and raised intracranial pressure. The role of osmotic therapy with either mannitol or hypertonic saline is based on the principle that these agents will help to remove water from brain tissue across an intact blood brain barrier. There is a debatation regarding the efficacy of hypertonic saline (HTS) versus mannitol in traumatic brain injury when are given in equiosmolar doses. Patients and Methods:An interventional study carried out at trauma and surgical critical care units in Zagazig University Hospital during the period from march 2016 to march 2017. It included ninety patients with different ages, sexes and Glasgow coma scale. The patients were randomly selected from the trauma and surgical critical care units, provided that the patients not received hyperosmolar drug before admission The patients were classified into three groups (thirty patients for each group) as the following: Group A: Included those who are treated with 20% mannitol. Group B: Included those who are treated with 3% hypertonic saline. Group C: Included those who are treated with 3% hypertonic saline alternating with 20% mannitol. Transcranial Doppler parameters especially pulsatility index were observed in the patients before every drug dose and 30 min after giving. Then we observed the change in value of cranial Doppler pulsatility index with subsequently interpretation of values.Results: There was no significant difference in equiosmolar dose (2ml/kg/6h) between mannitol 20% and hypertonic saline 3% in reducing noninvasive intracranial pressure (nICP) and pulsatility index (PI). Also, there were no significant differences in GCS at the end of treatment and GOS at one month from admission and decrease nICP between the two agents. Conclusion:This study recommends that in absence of contraindications, no superiority of hypertonic saline 3% over mannitol 20% as hyperosmolar therapy in TBI patients as the both are equally effective in reducing ICP and neurological outcome.

show abstract